RPC
MRK icon

Rossmore Private Capital’s Merck MRK Stock Holding History

Rossmore Private Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$105K – 358
2025
Q4 		$105K Buy
+1,000
New +$93.9K 0.01% 303

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rossmore Private Capital's MRK Position: Q1 2026 in Review

Rossmore Private Capital reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $1.12M and leaving 57,421 shares worth $6.96M. The position accounts for 0.61% of the portfolio, ranked #38.

Rossmore Private Capital first reported a position in MRK in Q4 2017 and has held it in 32 quarters since. The position peaked at $9.66M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rossmore Private Capital held 57,421 shares of Merck worth $6.96M as of Q1 2026.
  • Rossmore Private Capital sold 9,661 Merck shares in Q1 2026, an estimated $1.12M.
  • Merck made up 0.61% of Rossmore Private Capital's portfolio in Q1 2026, its #38 holding.
  • Rossmore Private Capital first reported a position in Merck in Q4 2017 and has held it in 32 quarters since.
  • Rossmore Private Capital's Merck position peaked at $9.66M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.